Hi Wasa,
ala seem to be eating cash too quickly. They have a long way to go down the clinical trials path.
There's always the possibility of a partner coming on board, but I think I will steer clear for the time being.
So many better opportunities around at the moment. Although this could change quickly in the future. I'll keep watching.
They do have a low mkt cap, which is appealing. But then so did ems and sud, and they were diluted to death.
Ann: Quarterly Appendix 4C and Activities Report, page-6
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $152.5M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $38.90K | 263.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 624656 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 628807 | 7 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |